Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: When would we know.....
Looking at the sharecounts from last years 13G and then what was reported in both DEF 14A's last year, I don't see any filings for sales other than the SB-2/A's that diluted the OS when warrants matured IMO. And we know about the repurchased warrants. Just trying to get a infofix on their sharecount that I thought declined last year........   
Share
New Message
Please login to post a reply